|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM298879247 |
003 |
DE-627 |
005 |
20240718232217.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2019 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1107/S1600577519005113
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1474.xml
|
035 |
|
|
|a (DE-627)NLM298879247
|
035 |
|
|
|a (NLM)31274418
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Stachowski, Timothy
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Structural consequences of transforming growth factor beta-1 activation from near-therapeutic X-ray doses
|
264 |
|
1 |
|c 2019
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 17.02.2020
|
500 |
|
|
|a Date Revised 18.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Dissociation of transforming growth factor beta-1 (TGFβ-1) from the inhibitory protein latency-associated peptide (LAP) can occur from low doses of X-ray irradiation of the LAP-TGFβ-1 complex, resulting in the activation of TGFβ-1, and can have health-related consequences. Using the tools and knowledge developed in the study of radiation damage in the crystallographic setting, small-angle X-ray scattering (SAXS) and complementary techniques suggest an activation process that is initiated but not driven by the initial X-ray exposure. LAP is revealed to be extended when not bound to TGFβ-1 and has a different structural conformation compared to the bound state. These studies pave the way for the structural understanding of systems impacted at therapeutic X-ray doses and show the potential impact of radiation damage studies beyond their original intent
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a SAXS
|
650 |
|
4 |
|a latency-associated peptide
|
650 |
|
4 |
|a radiation damage
|
650 |
|
4 |
|a transforming growth factor beta-1
|
650 |
|
7 |
|a Peptides
|2 NLM
|
650 |
|
7 |
|a Protein Precursors
|2 NLM
|
650 |
|
7 |
|a TGFB1 protein, human
|2 NLM
|
650 |
|
7 |
|a Transforming Growth Factor beta
|2 NLM
|
650 |
|
7 |
|a Transforming Growth Factor beta1
|2 NLM
|
650 |
|
7 |
|a latency-associated propeptide, TGF-beta
|2 NLM
|
700 |
1 |
|
|a Grant, Thomas D
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Snell, Edward H
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of synchrotron radiation
|d 1994
|g 26(2019), Pt 4 vom: 01. Juli, Seite 967-979
|w (DE-627)NLM09824129X
|x 1600-5775
|7 nnns
|
773 |
1 |
8 |
|g volume:26
|g year:2019
|g number:Pt 4
|g day:01
|g month:07
|g pages:967-979
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1107/S1600577519005113
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_2005
|
951 |
|
|
|a AR
|
952 |
|
|
|d 26
|j 2019
|e Pt 4
|b 01
|c 07
|h 967-979
|